Refractory AML
Oncology·MeSH: Hematologic Neoplasms
6 drugs in development·6 companies·1 clinical trial
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| uproleselan | Apollomics Inc. (APLM) |
Phase 2(1)
| Drug | Company |
|---|---|
| vcar33 | Vor Biopharma Inc. (VOR) |
Phase 1(3)
Unknown(1)
| Drug | Company |
|---|---|
| uproleselan | CRESCENT BIOPHARMA, INC. (CBIO) |
Compare drugs
Frequently asked questions
How many drugs are in development for Refractory AML?
BioSniper tracks 6 drugs in development for Refractory AML across 6 companies.
How many clinical trials target Refractory AML?
There are 1 clinical trial targeting Refractory AML tracked by BioSniper.
Deep-dive into Refractory AML
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis